September 2023 Newsletter
Safe Biologics
NOVEMBER 12, 2023
6 would prevent the HHS Secretary from requiring a switching study as part of the data package to receive the interchangeable designation. First approved in 2014 to treat one condition, melanoma, Merck now lists 19 separate conditions it can treat — a massive boon for desperate patients. However, S.6 ASBM surveys of U.S.
Let's personalize your content